Citrulline
Summary
An amino acid that raises nitric oxide bioavailability more effectively than arginine itself. Meta-analyses show small, marginal benefits for high-intensity performance, reps to failure, and post-exercise soreness.
Mechanism
Oral citrulline is converted to arginine, primarily in the kidneys, raising plasma arginine and nitric oxide bioavailability, more effectively than oral arginine itself. Nitric oxide drives vasodilation and increased skeletal-muscle blood flow.
Reported effects
Ratings are relative to peers in the same category, not absolute claims.
Studied dosing: research context
Performance trials most commonly use 6-8 g of citrulline malate taken acutely 1-2 hours before exercise (8 g is the most common dose; at a 2:1 ratio that is about 5.3 g of L-citrulline). Chronic L-citrulline trials typically use 3-6 g/day. These are doses used in research, not guidance.
Research context only. This is not a recommendation.
Safety
Generally well tolerated in trials. Stomach discomfort was reported in roughly 15% of subjects in the landmark Pérez-Guisado trial.
Limitations
Individual trials show mixed results with small samples (roughly 12-40 subjects); benefits are marginal rather than transformative. Most performance studies use citrulline malate, so the independent contribution of malate versus citrulline itself is unresolved.
References
- Trexler et al., Sports Med (2019): meta-analysis of citrulline and high-intensity strength/power performance
- Pérez-Guisado & Jakeman, J Strength Cond Res (2010): citrulline malate, anaerobic performance, and soreness
- Rhim et al., J Sport Health Sci (2020): meta-analysis of citrulline, soreness, and perceived exertion